Glyburide not a first-line treatment for gestational diabetes

1399 Views

eMediNexus 02 May 2018

New research examining the effect of glyburide vs subcutaneous insulin on perinatal complications among women with gestational diabetes published online May 1, 2018 in JAMA recommends against glyburide, an oral sulfonylurea drug, as a first-line treatment for gestational diabetes.

To comment on this article,
create a free account.

Already registered?

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.